<DOC>
	<DOC>NCT00750178</DOC>
	<brief_summary>This study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of MK0683 in patients with advanced cancer.</brief_summary>
	<brief_title>A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK0683 in Patients With Advanced Cancer (0683-008)</brief_title>
	<detailed_description />
	<mesh_term>Vorinostat</mesh_term>
	<criteria>Patients 18 years or older Must agree to consume high fat meal and agree to fasting conditions Limit alcohol consumption Patient has a history of drug or alcohol abuse within 5 years of start of study Patient is known to have HIV Patient has participated in another investigational study within 4 weeks of start of study Patient cannot stop taking certain medications or herbal remedies Patient will require immunologic, radiation, surgery, or chemotherapy during the study Patient requires frequent blood transfusions Female patient is pregnant or nursing Patient has an active Hepatitis B or C infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>